Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP) is a standardized multiple micronutrient supplement (MMS) formulation specifically designed for pregnant women in low- and middle-income countries. Developed through a consensus between UNICEF, the World Health Organization (WHO), and the United Nations University (UNU), the preparation contains 15 essential micronutrients: iron (30 mg), folic acid (400 µg), vitamin A, vitamin D, vitamin E, vitamin C, vitamins B1, B2, B3, B6, and B12, as well as zinc, selenium, copper, and iodine. UNIMMAP is intended to replace standard iron-folic acid (IFA) supplementation to better address the high prevalence of multiple micronutrient deficiencies. Its primary clinical goals are to reduce maternal anemia and improve neonatal outcomes, including reducing the risk of low birth weight (LBW), small-for-gestational-age (SGA) births, and preterm delivery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on United Nations International Multiple Micronutrient Antenatal Preparation.